Furthermore, SCC demonstrates lower expression levels of PIAS3 compared to adenocarcinoma and normal epithelium, in vitro and in vivo, by immunohistochemistry and western blotting (Fig.1, 2, and 4), consistent with our previous published data. The gene discussed is PIAS3; the disease is adenocarcinoma.